CD9 and Alzheimer disease: The newly discovered interaction between CD9 and TREM2 isoforms raises the prospect that TREM2 isoforms could be playing a role in cell–cell interaction within the same cell type or between different types of cells relevant to brain immunomodulation and, by extension, to AD.